ClinicalTrials.gg
Not yet recruitingNCT07926880Updated Nov 9, 2026

Letter-Writing Add-On to Brief Motivational Intervention for Alcohol Use

An interventional study of Brief Motivational Intervention and SDT-Informed Letter-Writing Task in Heavy Drinking and Alcohol Drinking, sponsored by Wayne State University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Wayne State University · Not applicable, Interventional, and Treatment

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot clinical trial is to learn whether adding a brief letter-writing exercise, grounded in Self-Determination Theory (SDT), to a brief motivational intervention (BMI) for alcohol use is feasible and acceptable, and to obtain preliminary estimates of its effects on psychological needs and motivation among adults who drink heavily and sometimes think about or wish they could cut back on their drinking.

The main questions it aims to answer are: (1) Is it feasible to integrate the letter-writing task into an SDT-informed BMI (recruitment, session completion, letter completion, retention)? (2) Do participants rate the letter-writing task as acceptable, appropriate, and feasible? (3) Compared with a neutral writing task, is the letter-writing task associated with higher perceived autonomy, competence, and relatedness, perceived competence for reducing drinking, and autonomous motivation?

Researchers will compare a BMI plus a neutral writing task with the same BMI plus the letter-writing task. Participants will complete a brief online screening survey; take part in a single 45-60-minute Zoom session that includes questionnaires, a 25-30-minute motivational interview, random assignment to either write an advice letter to another participant who has also thought about reducing their drinking or copy a neutral paragraph, and post-session questionnaires; and complete a 10-15-minute online follow-up survey about motivation, perceived competence, and alcohol use approximately one month later.

02

Conditions studied

  • Heavy Drinking
  • Alcohol Drinking

Browse trials for

03

In context

Alcohol Drinking

701 studies on the registry are indexed under Alcohol Drinking; 133 are open to participants now.

This study's planned enrollment of 86 is below the median of 122 across 607 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

Wayne State University is the lead sponsor of 230 studies on the registry; 35 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Resides in the United States
  • Meets the National Institute on Alcohol Abuse and Alcoholism heavy-drinking criteria in the past month
  • Answers Yes to "Do you sometimes think about reducing or wish you could reduce your alcohol use?"
  • Has internet access and a device capable of video conferencing via Zoom

Exclusion criteria

Exclusion Criteria:

  • Failure to meet the inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (estimated)

Study arms

  • Experimental
    BMI + Letter-Writing Condition

    Behavioral: Brief Motivational Intervention · Behavioral: SDT-Informed Letter-Writing Task

  • Active comparator
    BMI + Neutral Writing Condition

    Behavioral: Brief Motivational Intervention · Behavioral: Neutral Writing Task

Interventions

  • BehavioralBrief Motivational Intervention

    Participants will receive a brief, one-on-one, motivational intervention delivered via Zoom by a doctoral student in clinical psychology.

  • BehavioralSDT-Informed Letter-Writing Task

    Immediately after the brief motivational intervention, participants write a brief advice letter to another study participant who has also thought about reducing their drinking but sometimes struggles with motivation. Prompts target autonomy, competence, and relatedness.

  • BehavioralNeutral Writing Task

    Immediately after the brief motivational intervention, participants copy a technical paragraph on office supply inventory management that matches the letter-writing task in length and duration.

06

What researchers measure

Primary outcomes

  1. Recruitment Feasibility: Enrollment Rate Among Eligible Individuals Who Accept an Invitation

    Percentage of eligible people who accept an invitation and then enroll (attend the Zoom session, consent, and begin the baseline survey).

    Time frame: From accepting the invitation to the Zoom session (up to 21 days)

  2. Session Completion Rate

    Percentage of enrolled participants who complete all parts of the Zoom session.

    Time frame: Day 1

  3. Letter Completion Rate

    Percentage of participants assigned to letter writing who complete a letter during the session.

    Time frame: Day 1

  4. Acceptability of the Letter-Writing Task (Acceptability of Intervention Measure)

    Mean of 4 Acceptability of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater acceptability. Letter-writing participants only.

    Time frame: Day 1

  5. Appropriateness of the Letter-Writing Task (Intervention Appropriateness Measure)

    Mean of 4 Intervention Appropriateness Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater appropriateness. Letter-writing participants only.

    Time frame: Day 1

  6. Feasibility of the Letter-Writing Task (Feasibility of Intervention Measure)

    Mean of 4 Feasibility of Intervention Measure items, rated 1 (completely disagree) to 5 (completely agree); higher scores mean greater feasibility. Letter-writing participants only.

    Time frame: Day 1

Secondary outcomes

  1. Retention at One-Month Follow-Up

    Proportion of randomized participants who complete the one-month follow-up survey within the 14-day response window (days 30-44 after the session), overall and by arm.

    Time frame: Days 30 to 44 after the Zoom session

  2. State Autonomy for Drinking Decisions

    Single item rated 1 (not at all) to 7 (completely); higher scores mean greater autonomy.

    Time frame: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

  3. State Competence for Reducing Drinking

    Single item rated 1 (not capable at all) to 7 (extremely capable); higher scores mean greater competence.

    Time frame: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

  4. State Relatedness

    Single item rated 1 (not at all connected) to 7 (extremely connected); higher scores mean greater relatedness.

    Time frame: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

  5. Perceived Competence for Reducing Alcohol Use (Perceived Competence Scale)

    Mean of 4 items rated 1 (not at all true) to 7 (very true); higher scores mean greater perceived competence.

    Time frame: Start of the Zoom session (baseline), immediately post-intervention (Day 1), and 1 month after the Zoom session

  6. Autonomous Motivation to Reduce Alcohol Use (Treatment Self-Regulation Questionnaire)

    Autonomous motivation score (mean of items rated 1 to 7); higher scores mean more autonomous motivation.

    Time frame: Start of the Zoom session (baseline) and 1 month after the Zoom session

Other outcomes

  1. Heavy Drinking Days (Timeline Followback)

    Number of days in the past 30 with 5 or more (men) or 4 or more (women) standard drinks, measured with the Timeline Followback.

    Time frame: Start of the Zoom session (baseline) and 1 month after the Zoom session

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.

Of 328 non-industry interventional studies with no phase under Alcohol Drinking, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's planned 4 months is below that.

Counting every sponsor, half of 336 studies reached it within 24 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 31, 2026
First posted
Nov 9, 2026
StartEst.
Nov 2026
Primary completionEst.
Mar 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07926880
Responsible party
Emily Grekin (Associate Professor of Clinical Psychology; Associate Chair, Department of Psychology, Wayne State University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 2026 (estimated)
Primary completion
Mar 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Nov 9, 2026

Study contacts

Mariam A Souweidane
Contact
msouweidane@wayne.edu
734-707-8185

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion